✦ LIBER ✦

PUK14 A COST-UTILITY ANALYSIS IN A UK SETTING OF CINACALCET FOR SECONDARY HYPERPARATHYROIDISM IN END STAGE RENAL DISEASE

✍ Scribed by SJ Mealing; R Garside; M Pitt; R Anderson; R D'Sousa; K Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK24 A COST-UTILITY ANALYSIS OF CINACAL

✍ Iannazzo, S; Pradelli, L; Chiroli, S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PUK15 MODELLING COST-EFFECTIVENESS USING

✍ A Maetzel; C Cangialose; S Roze 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PSU18 Assessment of the Resource Use and

✍ R.D. Pockett; E. Cevro; D. Scott-coombes; G.H. Chamberlain 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Utility Analysis of Erythropoietin

✍ Thaweethamcharoen, Tanita; Sakulbumrungsil, Rungpetch; Nopmaneejumruslers, Cherd 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 549 KB

Cost-Effectiveness of Early versus Late

✍ Joshua A. Ray; Rohit Borker; Beth Barber; William J. Valentine; Vasily Belozerof 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

PUK14 INPATIENT COSTS AND CLINICAL OUTCO

✍ Y Li; JY Friedman; BF O'Neal; MJ Hohenboken; RI Griffiths; ME Stryjewski; KA Sch 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB